Status:
COMPLETED
Clinical Investigation to Examine Toothpaste Effect on Oral Bacteria
Lead Sponsor:
Colgate Palmolive
Conditions:
Oral Bacteria Levels in the Mouth
Eligibility:
All Genders
22-58 years
Phase:
PHASE4
Brief Summary
The primary objective was to evaluate the antibacterial effects of two toothpastes containing 0.3% triclosan, 2% copolymer and 0.234% sodium fluoride in a silica base as compared to a control regular ...
Eligibility Criteria
Inclusion
- Males and females in good general health aged 18 to 70 years.
- A willingness to read, understand, and sign the Informed Consent Form after the nature of the study has been fully explained to them. Subject should demonstrate a willingness to comply with all study procedures and sampling schedules.
- A minimum of 20 natural teeth with facial and lingual scorable surfaces.
- Adequate oral hygiene and no signs of oral neglect.
- Good periodontal health. Enrolled subjects will have no more than five periodontal pockets of 5 mm.
- Subjects with gingival index greater than or equal to 1.0 (Loe-Silness Index) and plaque index greater than or equal to 1.5 (Turesky modification of Quigley-Hein Index) will be enrolled.
Exclusion
- History of significant adverse effects following use of oral hygiene products such as toothpastes and mouthrinses. Allergy to personal care/consumer products or their ingredients.
- Teeth that are grossly carious, fully crowned or extensively restored on facial and/or lingual surfaces, orthodontically banded, abutments, or third molars
- History of diabetes or hepatic or renal disease, or other serious medical conditions or transmittable diseases, e.g. heart disease or AIDS.
- History of rheumatic fever, heart murmur, mitral valve prolapse or other conditions requiring prophylactic antibiotic coverage prior to invasive dental procedures.
- Subjects on antibiotic, anti-inflammatory or anticoagulant therapy during the month preceding the baseline exam.
- Significant oral soft tissue pathology, systemically related gingival enlargement, severe gingivitis (based on a visual examinations).
- History of active severe periodontal disease with bleeding gums and loose teeth.
- Gross dental caries, severe generalized cervical abrasion and/or enamel abrasion, large fractured or temporary restorations (based on visual examinations).will not be included in the tooth count.
- Fixed or removable orthodontic appliance or removable partial dentures.
- Participation in a dental plaque/gingivitis clinical study involving oral care products, within the last 30 days. History of dental prophylaxis or treatments in the past month.
- Self reported pregnancy or lactation.
- History or current use of objects to pierce the lips or tongue.
- Subjects known to be an alcoholic, or a recovering alcoholic.
- History or current use of recreational drugs.
Key Trial Info
Start Date :
January 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2014
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT02194621
Start Date
January 1 2014
End Date
March 1 2014
Last Update
April 15 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rutgers School of Dental Medicine
Newark, New Jersey, United States, 07107